Congratulations to Vigonvita Life Sciences Co., Ltd. （2630.HK） on its Successful Listing

Congratulations to Vigonvita Life Sciences Co., Ltd. （2630.HK） on its successful Listing on the Mainboard of HKSE on 6 Nov 2025

Vigonvita Life Sciences Co., Ltd. （the “Vigonvita”） is a biopharmaceutical company engaged in the discovery, acquisition, development, and commercialization of small-molecule drugs in its strategically focused therapeutic areas, namely neuropsychiatry and reproductive health.

With regard to this listing application, AVISTA Group is honored to be engaged in providing valuation services related to share-based compensation and intangible asset impairment test.

Congratulations again Vigonvita Life Sciences Co., Ltd. （2630.HK） on its successful listing. The issue price of the shares is  HKD 33.37 per share, and the amount of funds raised is HKD 587 million.